Lu S - Search Results

1

Genome-wide mutant fitness profiling identifies nutritional requirements for optimal growth of Yersinia pestis in deep tissue.

Palace SG, Proulx MK, Lu S, Baker RE, Goguen JD. Palace SG, et al. Among authors: lu s. mBio. 2014 Aug 19;5(4):e01385-14. doi: 10.1128/mBio.01385-14. mBio. 2014. PMID: 25139902 Free PMC article.

2

Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.

Wang S, Goguen JD, Li F, Lu S. Wang S, et al. Among authors: lu s. Vaccine. 2011 Sep 9;29(39):6802-9. doi: 10.1016/j.vaccine.2010.12.062. Epub 2011 Jan 1. Vaccine. 2011. PMID: 21199697 Free PMC article.

3

Evaluation of the role of LcrV-Toll-like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis.

Pouliot K, Pan N, Wang S, Lu S, Lien E, Goguen JD. Pouliot K, et al. Among authors: lu s. Infect Immun. 2007 Jul;75(7):3571-80. doi: 10.1128/IAI.01644-06. Epub 2007 Apr 16. Infect Immun. 2007. PMID: 17438030 Free PMC article.

4

Relative immunogenicity and protection potential of candidate Yersinia Pestis antigens against lethal mucosal plague challenge in Balb/C mice.

Wang S, Joshi S, Mboudjeka I, Liu F, Ling T, Goguen JD, Lu S. Wang S, et al. Among authors: lu s. Vaccine. 2008 Mar 20;26(13):1664-74. doi: 10.1016/j.vaccine.2008.01.024. Epub 2008 Feb 4. Vaccine. 2008. PMID: 18291562 Free PMC article.

5

Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines.

Wang S, Mboudjeka I, Goguen JD, Lu S. Wang S, et al. Among authors: lu s. Vaccine. 2010 Feb 23;28(8):2011-9. doi: 10.1016/j.vaccine.2009.10.059. Vaccine. 2010. PMID: 20188257 Free PMC article.

6

A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague.

Wang S, Heilman D, Liu F, Giehl T, Joshi S, Huang X, Chou TH, Goguen J, Lu S. Wang S, et al. Among authors: lu s. Vaccine. 2004 Sep 3;22(25-26):3348-57. doi: 10.1016/j.vaccine.2004.02.036. Vaccine. 2004. PMID: 15308359 Free PMC article.

7

Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine.

Li W, Wang S, Lu S. Li W, et al. Among authors: lu s. Vaccines (Basel). 2013 Dec 27;2(1):36-48. doi: 10.3390/vaccines2010036. Vaccines (Basel). 2013. PMID: 26344467 Free PMC article.

8

The dynamics of immunoglobulin V-gene usage and clonotype expansion in mice after prime and boost immunizations as analyzed by NGS.

Farfán-Arribas DJ, Liu S, Wang S, Lu S. Farfán-Arribas DJ, et al. Among authors: lu s. Hum Vaccin Immunother. 2017 Dec 2;13(12):2987-2995. doi: 10.1080/21645515.2017.1379638. Epub 2017 Oct 19. Hum Vaccin Immunother. 2017. PMID: 29049006 Free PMC article.

9

A novel DDB2-ATM feedback loop regulates human cytomegalovirus replication.

E X, Savidis G, Chin CR, Wang S, Lu S, Brass AL, Kowalik TF. E X, et al. Among authors: lu s. J Virol. 2014 Feb;88(4):2279-90. doi: 10.1128/JVI.03423-13. Epub 2013 Dec 11. J Virol. 2014. PMID: 24335308 Free PMC article.

10

RNA interference-mediated targeting of human cytomegalovirus immediate-early or early gene products inhibits viral replication with differential effects on cellular functions.

Xiaofei E, Stadler BM, Debatis M, Wang S, Lu S, Kowalik TF. Xiaofei E, et al. Among authors: lu s. J Virol. 2012 May;86(10):5660-73. doi: 10.1128/JVI.06338-11. Epub 2012 Mar 21. J Virol. 2012. PMID: 22438545 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,955 results

Search Page

Filters